Cara Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Tvardi Therapeutics

13/05/2024 22:22

* Cara Therapeutics Inc  CARA.OQ  reported a quarterly
adjusted
loss of 56 cents​​ per share for the quarter ended in March,
lower than the same quarter last year, when the company reported
EPS of -49 cents.  The mean expectation of five analysts for the
quarter was for a loss of 40 cents per share. Wall Street
expected results to range from -43 cents to -35 cents per share.
    * Revenue fell 75.5% to $1.51 million from a year ago;
analysts
expected $1.69 million. 
    * Cara Therapeutics Inc's reported EPS for the quarter was a
loss
of 56 cents​.
    * The company reported a quarterly loss of $30.7 million.
    * Cara Therapeutics Inc shares had fallen by 21.4% this
quarter and lost 3.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Cara Therapeutics
Inc is $5.00 
This summary was machine generated from LSEG data May 13 at
09:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.40          -0.56          Missed
 Dec. 31 2023      -0.41          -0.59          Missed
 Sep. 30 2023      -0.52          -0.52          Met
 Jun. 30 2023      -0.54          -0.58          Missed